Updated:
Broadfin Capital
Broadfin Capital is a global equity healthcare manager based in Melville, New York. Founded in 2005, the company focuses on the healthcare sector and employs a...
Broadfin Capital
Broadfin Capital is a global equity healthcare manager based in Melville, New York. Founded in 2005, the company focuses on the healthcare sector and employs a value-oriented investment strategy based on fundamental research. It invests in medical technology, pharmaceuticals, and biotechnology sectors across all market capitalizations, managing binary event risks.
General information
Firm type
Asset Manager
Year founded
2005
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
San Francisco, CA · Boston, MA
Principals
Kevin Kotler
Founder & Portfolio Manager
Sector focus
Frequently asked questions
Who made investment decisions at Broadfin Capital?
Kevin Kotler, the founder, served as the sole portfolio manager and made all final investment decisions. He built the firm after working as a healthcare analyst and maintained a flat structure without co-portfolio managers, which kept decision-making concentrated and fast.
What was Broadfin's most notable investment?
Auspex Pharmaceuticals was Broadfin's signature win. The firm built an 8.4% stake at an average cost around $15 per share and realized over $150 million when Teva Pharmaceutical Industries acquired Auspex for $101 per share in cash in 2015, a return exceeding 10x.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: